Evaluation of eight cases of confirmed Bordetella bronchiseptica infection and colonization over a 15-year period

Clinical Microbiology and Infection

Volumn 17, Issue 2, 2011, Pages 201-203

  Wernli, D ^a   Emonet, S ^a   Schrenzel, J ^a   Harbarth, S ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bordetella bronchiseptica; Case series; Clinical study; Epidemiology; Humans; Outcome; Switzerland

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; DNA 16S; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BORDETELLA BRONCHISEPTICA; BORDETELLA BRONCHISEPTICA INFECTION; BRONCHITIS; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MIXED INFECTION; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

BORDETELLA BRONCHISEPTICA;

EID: 78751624389     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03258.x     Document Type: Article

References (11)

1. Woolfrey BF, Moody JA. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 1991; 4: 243-255.
2. Garcia San Miguel L, Quereda C, Martinez M, Martin-Davila P, Cobo J, Guerrero A. Bordetella bronchiseptica cavitary pneumonia in a patient with AIDS. Eur J Clin Microbiol Infect Dis 1998; 17: 675-676.
3. Le Coustumier A, Gueirard P, Guiso N. Epidémiologie des infections humaines àBordetella bronchiseptica. Médecine et Maladies Infectieuses 1995; 25 (suppl 3): 1243-1247.
4. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18: 326-382.
5. Spilker T, Liwienski AA, LiPuma JJ. Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis. Clin Microbiol Infect 2008; 14: 504-506.
6. Lorenzo-Pajuelo B, Villanueva JL, Rodriguez-Cuesta J et al. Cavitary pneumonia in an AIDS patient caused by an unusual Bordetella bronchiseptica variant producing reduced amounts of pertactin and other major antigens. J Clin Microbiol 2002; 40: 3146-3154.
7. Ner Z, Ross LA, Horn MV et al. Bordetella bronchiseptica infection in pediatric lung transplant recipients. Pediatr Transplant 2003; 7: 413-417.
8. Bose A, Javaid W, Ashame E, Kiska D, Riddell S, Blair D. Bordetella bronchiseptica: an emerging nosocomial pathogen in immunocompromised patients. Clin Microbiol Newsl 2008; 30: 117-119.
9. Speakman AJ, Binns SH, Dawson S, Hart CA, Gaskell RM. Antimicrobial susceptibility of Bordetella bronchiseptica isolates from cats and a comparison of the agar dilution and E-test methods. Vet Microbiol 1997; 54: 63-72.
10. Gopinathan L, Kirimanjeswara GS, Wolfe DN, Kelley ML, Harvill ET. Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. Microbes Infect 2007; 9: 442-448.
11. Goebel EM, Zhang X, Harvill ET. Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. PLoS ONE 2009; 4: e6778.